Tablet and process for making the same

{
  "publication_number": "US6258381B1",
  "country": "US",
  "kind": "B1",
  "title": "Tablet and process for making the same",
  "abstract": "A tablet and process for making the same is provided. The tablet is made from a granular agglomerate comprising a mixture of at least one active ingredient and a binder. The granular agglomerate is heated to melt the binder only at or near its surface, and then cooled, such that the melted binder solidifies into a substantially continuous phase, thereby forming a fused layer on the outside of the tablet.",
  "claims": [
    "1. A process for making a tablet comprising a granular agglomerate core and a fused layer surrounding said core, comprising: a) forming a granular agglomerate core from a mixture comprising at least one active ingredient and a binder having a melting point of about 20 to about 180° C.; b) heating the granular agglomerate core at a temperature and for a period of time to melt the binder only at or near the surface of the granular agglomerate core; and c) cooling the granular agglomerate core such that the melted binder solidifies into a substantially continuous phase of said fused layer.",
    "2. The process of claim 1, wherein said tablet has a hardness of up to about 20 kp/cm 2.",
    "3. The process of claim 1, wherein said binder is selected from the group consisting of fats, waxes, water soluble polymers, long chain alcohols and their derivatives, and mixtures thereof.",
    "4. The process of claim 3, wherein said binder is selected from the group consisting of hydrogenated vegetable oil, polyethylene glycol, waxes, and mixtures thereof.",
    "5. The process of claim 1, wherein said active ingredient is selected from the group consisting of acetaminophen, ibuprofen, pseudoephedrine, dextromethorphan, diphenhydramine, chlorpheniramine, calcium carbonate, magnesium hydroxide, magnesium carbonate, magnesium oxide, aluminum hydroxide, mixtures thereof, and pharmaceutically acceptable salts thereof.",
    "6. The process of claim 1, wherein said fused layer has a thickness of about 0.01 to about 2 mm.",
    "7. The process of claim 1, wherein said binder comprises less than 20 weight percent of the granular agglomerate.",
    "8. The process of claim 1, where the granular agglomeratc is fonned by rotary compaction.",
    "9. The process of claim 1, further comprising applying at least one outer coating over the fused layer.",
    "10. A tablet made by the process of claim 1.",
    "11. The tablet of claim 10, wherein the binder is selected from the group consisting of hydrogenated vegetable oil, polyethylene glycol, waxes, long chain alcohols and their derivatives and mixtures thereof, and the active ingredient is selected from the group consisting of acetaminophen, ibuprofen, pseudoephedrine, dextromethorphan, diphenhydramine, chlorpheniramine, calcium carbonate, magnesium hydroxide, carbonate, or oxide, aluminum hydroxide, mixtures thereof, and pharmaceutically acceptable salts thereof.",
    "12. A tablet comprising a granular agglomerate core and a fused layer surrounding said core, wherein said core and said fused layer have the same composition comprising at least one active ingredient and a binder having a melting point of about 20 to about 180° C., and further wherein said binder forms a substantially continuous phase within said fused layer.",
    "13. The tablet of claim 12 having a hardness of up to about 20 kp/Cm 2.",
    "14. The tablet of claim 12, wherein said binder is selected from the group consisting of fats, waxes, water soluble polymers, long chain alcohols and their derivatives, and mixtures thereof.",
    "15. The tablet of claim 14, wherein said binder is selected from the group consisting of hydrogenated vegetable oil, polyethylene glycol, waxes, and mixtures thereof.",
    "16. The tablet of claim 12, wherein said active ingredient is selected from the group consisting of acetaminophen, ibuprofen, pseudoephedrine, dextromethorphan, diphenhydramine, chlorpheniramine, calcium carbonate, magnesium hydroxide, magnesium carbonate, magnesium oxide, aluminum hydroxide, mixtures thereof, and pharmaceutically acceptable salts thereof.",
    "17. The tablet of claim 12, wherein said fused layer has a thickness of about 0.01 to about 2 mm.",
    "18. The tablet of claim 12 further comprising at least one outer coating disposed over the fused layer.",
    "19. The tablet of claim 12 wherein the friability of said tablet is less than about 2.0%.",
    "20. The tablet of claim 12 wherein the friability of said tablet is less than about 0.75%."
  ],
  "cpc": [
    "A61K 31/485",
    "A61K 31/135",
    "A61K 31/137",
    "A61K 31/167",
    "A61K 31/265",
    "A61K 31/4402",
    "A61K 9/2077"
  ],
  "assignees": [
    "MCNEIL PPC INC"
  ],
  "filing_date": "2000-02-11",
  "publication_date": "2001-07-10",
  "grant_date": "2001-07-10",
  "priority_date": "2000-02-11",
  "application_number": "US-50259400-A",
  "family_id": "23998514",
  "citations": [
    "EP0070127A2",
    "EP0192460B1",
    "US4327076A",
    "US4609543A",
    "US4684534A",
    "US4828845A",
    "US5215755A",
    "US5320848A",
    "US6024981A",
    "US6060078A",
    "WO9313758A1",
    "WO9917771A1"
  ]
}